CA4576376012 - Common Stock
Get insights into the top gainers and losers of Wednesday's after-hours session.
InMed Pharmaceuticals (INM) Friday announced the appointment of Netta Jagpal as Chief Financial Officer and Corporate Secretary, effective February 20. Jagpal j
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
InMed Pharmaceuticals files prospectus for resale of 12.57M shares by selling shareholders, not an offer to sell securities.
Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones.
EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut.
BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial.
InMed Pharmaceuticals stock is falling on Wednesday after shares of INM underwent a massive rally on Tuesday alongside study results.
Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.
InMed Pharmaceuticals announces a $5.2 million private placement offering. Read more.
Here's what investors in INM stock may want to watch, given the company's recent impressive early results from an Alzheimer's drug candidate.
InMed Pharmaceuticals receives notice from Nasdaq for non-compliance with minimum bid price requirement. 180-day period given to rectify the issue.